Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here's another link you might enjoy.
http://arminvestorday.com/company-presentations/#act
They're presenting next week on Wednesday the 26th... That's inevitable as well.
I agree, and don't forget... Completion of phase 1 and TLD are around the corner and more importantly Inevitable.
Wow! That right there is a catalyst find Gs. I mentioned before that there seems to be a feeling of an attempt to "monopolize" the field of regenerative medicine. These days in the overall capitalist world we live in its all about branding and "reach". BioHeart is seemingly becoming a huge brand by reaching out and touching different sectors of illnesses that can be eased or cured by regenerative medicine. IMO.
Yes sir. What matters right now is heading into the weekend in the green... No matter how light or how dark the green. IMO
That's your argument?? 3 months ago?? "Since December" is not that long of a wait... But that is an opinion were talking about of course. What may be a long time for you may not be a long time for others however, the TLD is coming... That is inevitable. When TLD is announced it will trump IMO all opinions about ACTC and the carefully slow pace they're working at I order to ensure success. My opinion.
Well the news released today is really not the type of news that will rally a stock, but they are both great indications of long term value. I know that BioHeart charges for these courses on harvesting stem cells. Don't forget 10 days from now we should be getting the 10K. IMO
Nice find GSdubb!
Mirror is for Myocell.
Myocell SDF-1 "MyoCell SDF-1 has received approval from the FDA to begin human clinical trials and is intended to be an improvement to MyoCell"
It's the second generation of Myocell. I believe it is a great strategy to already have a successor to Myocell.
ACTC has never ran on "fumes". ACTC is not a locomotive.
Rather and more importantly... ACTC will soon complete phase 1, release TLD and announce phase 2. It's inevitable.
I respect your opinion, at minimum. However... At this stage, TLD announcement is all that matters.
It will arrive precisely when it does. That is all that matters.
ACTC is going to new heights once TLD is announced. It will be announced, that is inevitable... Therefore new heights are inevitable. IMO
Holding strong today. I suspect the slow climb begins tomorrow. IMO
Regen Med Investor Day On Wednesday the 26th... NEJM on THURSDAY the 27th?? Anyone else think that's the plan?
I don't believe we would hear any news about SDF-1 until after a phase 3 update on mirror. I feel like a massive corporate update along with the 10k and news leading up to it is their current strategy. There is definitely a lot going on with BioHeart. Some sort of "monopolization" approach in the regenerative medicine field. It would be awesome to hear an update on SDF-1 but I feel like the only reason they would update us on that, let's say tomorrow, is because a mirror update is expected with the 10K release. I'm looking forward to what I think will be a steady rise in share price everyday next week leading up to Monday the 31st. New highs with new support levels after the 10K. All IMO. Very positive about BHRT long term.
BioHeart is hiring according to their latest tweet which has a link straight to their website's careers section.
#Leadership in the #cardiology industry this century is based on a core competency in #biologics. Have what it takes? bit.ly/1nDL358
http://www.bioheartinc.com/Careers
I actually prefer "fully funded by BioHeart" I don't have trust issues in that department. For the stocks sake though I understand that most investors prefer to know where the money is coming from specifically... Exactly.
Taking into consideration the article I posted and BioHeart tweeted... The MD in the article is Jon George, MD, Interventional Cardiologist, Temple University School of Medicine
BioHeart then went on to tweet
Bioheart’s Scientific Advisory Board is composed of scientists, M.D.'s and Ph.D.s. See more: bit.ly/1nB8sUG
So I checked it out and saw listed:
George J. Magovern, M.D. Cardiac surgery Retired Chairman Department of Cardiothoracic Surgery Allegheny Hospital Pittsburgh, Pennsylvania
Note Pennsylvania.
So then I checked where the temple university school of medicine was and it turned out to be in Pennsylvania.
My question to you is, do you believe George J. Magovern M.D. Is Jon George, MD, just with his name disguised a bit since the information was intently kept under wraps as far as what companies phase 3 trials they were talking about?
Or am I looking to hard between the lines?? If I'm accurate, that means that continued phase 3 enrollment news is around the corner IMO.
Let's finish at .065!!!
Back to 100% buy indication after falling as low as 96% http://www.barchart.com/opinions/stocks/BHRT
Nice!
I think we should have a second look at part of the concluding paragraph of today's PR. We closed a .01 up or 22.2% but I think that close undervalues today's news in my opinion. So here it is.
BIOHEART ANNOUNCES JOINT VENTURE
WITH MAGNUM CELL THERAPIES 3/17/2014
"Bioheart and Magnum will work closely with the Honduran Ministry of Health to make Bioheart protocols part of the standard of care for patients in Honduras and neighboring countries. Bioheart will assume 10% ownership of Magnum Cell Therapies. Magnum will offer these therapies to the more than 8 million people living in Honduras as well as being a premier site for medical tourism"
Ok so we should get the 10K within 15 days beginning tomorrow if I read correctly. Not a problem. ACTC is in action and hard at work in cleaning up the past for a prosperous future. IMO.
Opinion noted. Waiting game indeed. IMO when ACTC finally hits the gas, it will trump any pot stock. (Although I'm saying that blindly as I haven't been following any pot stock, just a different biotech stock I hold that seems to have began its climb recently and finally)
It seems as though ACTC is steps away from being where we want it to be. As investors prefer PRs to every step taken forward, I believe that ACTC is taking a different approach and is going to make one giant leap to end up at where we want to be anyway. Hope that's not too vague of an opinion. With that said I feel that when the giant leap is made we will wake up to an onslaught of prime PRs overnight and/or in the same week. IMO
Do you believe it is possible that the last cohort was or is no longer required?? Remember they added a cohort during trials. It may be that with current data the FDA did not require final cohort. It is my opinion because it seems to be taking way too long and as of their last presentation slides, it's indicated that phase 1 is complete and phase 2 is in preparation. IMO
http://www.advancedcell.com/documents/0000/0481/act-corporate-presentation---bioceo---february-2014--print-version.pdf
Solid day today overall. The long run looks positive. The 10K is highly anticipated. BioHeart is taking very careful steps forward in order to ensure their success. IMO. GLTA
First, you have my FACTUAL response to how I easily created that response with PR headings. If anyone would like to try for themselves they can simply click on this link here:
http://www.bioheartinc.com/News-Events/NewsReleases/2014/Q1
Second, I do not work for any group making an attempt at a financial gain through this stock.
Third, what is your agenda?? Why are you so passionate about BHRT?? What is the reason why you feel compelled to enlighten people with your so called "facts"? If this stock is as bad as you say it is... Why are you here?? Why not move on to a board where you will not be so "stressed" over people who are blind to your alleged warnings?? WHY INVEST YOUR TIME IN SOMETHING YOU DONT FIND WORTH INVESTING IN??
I'm here because I believe in BioHeart. I believe in its science and in its management. I believe because I've done my research and all obvious signals IMO point to a great opportunity for mankind and long financial gains. GLTA
Really?? Like I said earlier this is the 21st century... I have the BioHeart website as one of my favorites. All I did was go to the web site and copy paste the links to the PRs...
Here's the link so you can find that FACT out for yourself.
P.S. My iPad really comes in hand
http://www.bioheartinc.com/News-Events/NewsReleases/2014/Q1
What pains me the most is that I'm in the middle of watching The Walking Dead new episode premier and I pause it just to respond to your posts that lack FACTS. IMO
Also, andyshow is my only alias.
Not even an undervalued stock getting ready to announce significant news in a 10K on the 31st of the month trading is in question?
No, it wasn't on "no news". Here's the news for you since you've clearly missed it, I believe. For the record, me stating you've missed it is not an attack since you stated "no news" and also claim to be a finder of facts for what I believe you mean penny stocks not pennies as in the currency.
3/4/2014
BIOHEART ANNOUNCES POSITIVE 6 MONTH DATA FROM ANGEL PHASE I TRIAL
1/29/2014
BIOHEART ANNOUNCES FIRST ADIPOSE DERIVED STEM CELL IMPLANTATION IN AZERBAIJAN
1/22/2014
BIOHEART ANNOUNCES EXCLUSIVE LICENSE IN VETERINARY MEDICINE FOR PATENTS FOR CANCER RELATED IMMUNOTHERAPY PRODUCTS
1/13/2014
BIOHEART, INC. TO PRESENT AT AMERICAN ACADEMY OF COSMETIC SURGERY
12/31/2013
BIOHEART, INC. TO PRESENT AT VAIL SYMPOSIUM’S WINTER PROGRAM ON CELL THERAPY
12/17/2013
BIOHEART ANNOUNCES CLINICAL STUDY FOR DRY MACULAR DEGENERATION
12/3/2013
BIOHEART, INC. ENTERS INTO INVESTMENT BANKING AGREEMENT WITH CASSEL SALPETER & CO.
12/2/2013
BIOHEART ANNOUNCES AGREEMENT WITH StemMD TO PROVIDE BIOHEART THERAPIES TO ITS NETWORK
11/26/2013
BIOHEART ANNOUNCES NEW CLINICAL SITE IN MEXICO
11/18/2013
BIOHEART'S PRESIDENT/CEO MIKE TOMAS NAMED CHAIR OF THE eMERGE INNOVATE ADVISORY BOARD OF eMERGE AMERICAS
11/4/2013
BIOHEART ANNOUNCES AGREEMENT WITH GLOBAL STEM CELL GROUP TO PROVIDE BIOHEART THERAPIES AND TRAINING
10/25/2013
BIOHEART ANNOUNCES AGREEMENT WITH ANOSIS TO DISTRIBUTE PRODUCTS IN THE MIDDLE EAST
10/16/2013
BIOHEART ANNOUNCES CONTRACT WITH AFRICAN-MIDDLE EAST MEDICAL (AFRIMID) TO BEGIN DISTRIBUTING STEM CELL PRODUCTS IN UGANDA
9/30/2013
BIOHEART ADDS TWO SERVICE PROVIDERS TO ITS TEAM OF RESOURCES
9/26/2013
BIOHEART ANNOUNCES POSITIVE PRELIMINARY DATA FROM PHASE I ANGEL TRIAL
9/24/2013
BIOHEART ANNOUNCES AGREEMENT WITH INVITRX TO LICENSE ADIPOSE DERIVED STEM CELLS
9/23/2013
BIOHEART BOOSTS TEAM WITH REGULATORY, FINANCE AND ADMINISTRATIVE EXPERTISE
8/28/2013
BANKER SHELDON T. ANDERSON ELECTED TO THE BOARD OF DIRECTORS OF BIOHEART, INC.
8/14/2013
BIOHEART'S PRESIDENT / CEO MIKE TOMAS APPOINTED TO WORKFORCE FLORIDA BOARD OF DIRECTORS BY GOVERNOR RICK SCOTT
8/9/2013
BIOHEART RECEIVES VALIDATED FDA REGISTRATION FOR TISSUE BANK ESTABLISHMENT
7/2/2013
BIOHEART ANNOUNCES PHASE III MIRROR TRIAL FOR MYOCELL INITIATED
You're welcome to create that assumption. If you asked me it tells a lot about what direction the insiders believe the stock is headed. I mean... I wouldn't care much for shares if I knew they weren't going to be worth anything. IMO
Well I did state "Also I check the board frequently and conveniently very quickly through the ihub apps installed in both devices."
And yes. I do sleep with both devices next to me, not on the bed but at arms length.
I'm happy to answer your questions by the way... though they aren't relative to the fact that BioHeart are a leading company amidst a paradigm shift in medicine.
You should change your alias to SHAREHOLDERFACTFINDER
I'm hoping/expecting for the announcements of new revenue streams (yes plural with an s), an update on our phase 3 mirror trial for Myocell, as well as the announcements of funding for all the recently announced clinical trials such as the dry Mac., erectile dysfunction, and the COPD trial. GLTA
Yes sir! Go BHRT!!
What are you referring too? I don't understand your question or approach... What do you believe in?
Shareholders of BioHeart. Easy answer.